In addition, TLR4-Thr399Ile has been associated with the presence of obesity, a comorbidity commonly found in patients with MASH, thus suggesting its indirect influence on liver disease via broader metabolic and inflammatory pathways [45]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.